BADRUN ZAMAN: Open Payments
NPI 1821601279 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 29 payments from 19 companies in 2025. Trend: 2023 $239 · 2024 $538 · 2025 $962
Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation | 2 | $118 |
| Eisai Inc. | 1 | $104 |
| Syndax Pharmaceuticals, Inc. | 1 | $94 |
| Daiichi Sankyo Inc. | 3 | $83 |
| GENZYME CORPORATION | 3 | $73 |
| Janssen Scientific Affairs, LLC | 1 | $63 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 2 | $42 |
Products named: RYTELO, Lenvima, REVUFORJ, Enhertu, DARZALEX, KEYTRUDA, LYNPARZA, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
